Falling HR, Not Beta Blockade, Key to Ivabradine Success in HFFalling HR, Not Beta Blockade, Key to Ivabradine Success in HF
In the SHIFT trial of the heart-rate#8211;lowering agent ivabradine, it was heart-rate reduction per se, not the level of accompanying beta-blocker therapy, that apparently accounted for the newer drug's observed benefits. Heartwire (Source: Medscape Today Headlines)

'House' medical adviser looks back
I'm proud of the medical work we did on House. Each week (for a total of 177), we showed millions of people a different, insidious way the human body can malfunction and how physicians might figure out the problem. (Source: CNN.com - Health)div id=medwormpbiMedWorm Sponsor Message:/i/b Have a look at a href=http://www.thepsychologydaily.comThe Psychology Daily/a, the new psychology portal powered by MedWorm, with all the latest psychology news and research updated daily./p/div